Valeant CEO reaches deal with Senate committee, contempt charges on hold

Valeant CEO reaches deal with Senate committee, contempt charges on hold-stat: A Senate committee called off a planned meeting Wednesday to discuss contempt charges against Valeant Pharmaceuticals chief executive Michael Pearson after he agreed to give a deposition for the panel’s investigation of rising drug prices.